Samsung Trumps Apple With Digital Health Announcement – Again

Yesterday, the Silicon Valley‒based division of Samsung known as the Strategy and Innovation Center (SSIC) hosted a launch event at the San Francisco Jazz Center. As product announcements go it was fairly typical and lasted just under 60 minutes

View article:
Samsung Trumps Apple With Digital Health Announcement – Again

Cornerstone Pharmaceuticals Clinical Data on CPI-613 to be Presented at ASCO 2014

CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that data from a Phase I clinical trial of its proprietary first-in-class …

Follow this link:
Cornerstone Pharmaceuticals Clinical Data on CPI-613 to be Presented at ASCO 2014

Cornerstone Pharmaceuticals Lead Compound CPI-613 Demonstrates Ability to Disrupt Growth of Cancer Cells

CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced that its first-in-class cancer metabolism targeted therapeutic, …

See the original post:
Cornerstone Pharmaceuticals Lead Compound CPI-613 Demonstrates Ability to Disrupt Growth of Cancer Cells

Re-energization of another unit of the 180 MW Mahanagdong Power Plant (Energy Development Corporation)

(Source: Energy Development Corporation) Energy Development Corporation 38th Floor, One Corporate Centre Building, Julia Vargas corner Meralco Avenue Ortigas Center, Pasig 1605,…

View article:
Re-energization of another unit of the 180 MW Mahanagdong Power Plant (Energy Development Corporation)

Seahorse Bioscience Inc. Announces Zhejiang University Graduate Biology Scholarship

BILLERICA, Mass., Jan. 15, 2014 /PRNewswire/ — Seahorse Bioscience, the world leader in cellular metabolic analyzers and assay kits for measuring real-time metabolism, has announced a scholarship agreement with Dr

See the article here:
Seahorse Bioscience Inc. Announces Zhejiang University Graduate Biology Scholarship

Cornerstone Pharmaceuticals Presents Updated Phase I Data for CPI-613 at 2013 American Society of Hematology Annual …

CRANBURY, N.J. — Cornerstone Pharmaceuticals, Inc., a leader in the growing field of cancer metabolism-based therapeutics, today announced updated results from a Phase I clinical study of its first-in-class …

See more here:
Cornerstone Pharmaceuticals Presents Updated Phase I Data for CPI-613 at 2013 American Society of Hematology Annual …